URAVIDEFBSEUravi Defence and Technology LtdHighNeutral
Announced Thu, 28 May · 20:58 IST

Audited(Standalone and Consolidated) Financial Results for the quarter and year ended 31st March,2026

Qualified OpinionRevenue DeclinePat NegativeEbitda Margin CompressionExceptional ItemRelated Party TransactionsResults View source PDF

URAVIDEF · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹118.29
prior close
₹119.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.4-0.5-0.6+1.4-2.7-2.0-2.5+0.2+1.4-4.5-1.1
Up moveDown movePending
AI summary

Uravi Defence and Technology Ltd reported FY2026 standalone revenue of Rs 3,862.05 Lakhs, down 6.6% from Rs 4,134.54 Lakhs in FY2025. Standalone PAT fell 26.3% to Rs 131.70 Lakhs (FY25: Rs 178.58 Lakhs) and EBITDA margin compressed from ~6.1% to ~4.4%. The company received an un-modified opinion on standalone financials but a modified opinion on consolidated financials — the key qualification relates to Spafax Group's profit of Rs 72.05 Lakhs being based on unaudited management accounts rather than audited statements. During the year, the company sold its 50.01% stake in SKL India (subsidiary) for Rs 1,125.20 Lakhs (loss on sale: Rs 116.80 Lakhs), and completed a four-tranche investment in Spafax International Holding Ltd, crossing 20% holding (now an associate at 39.61%). Additionally, 11,00,000 share warrants lapsed (credited Rs 907.50 Lakhs to retained earnings).

Likely market impact

Revenue and profit both declined year-on-year with margin compression. The modified opinion on consolidated results raises audit quality concerns, particularly around the Spafax associate income based on unaudited accounts. Shareholders should monitor the reliability of associate earnings and the company's ability to arrest the revenue decline.